John Lauerman
Stories by John Lauerman
Tencent-linked health AI developer Medopad raises $25m
Leaps by Bayer, an investment arm of Bayer AG, led the Series B funding round.
China’s Tencent taps Medopad’s AI tech for Parkinson’s treatment
Medopad said in February that it had signed deals worth $131 million with a number of Chinese companies, including Tencent.
Japan’s Takeda mulls bid for British firm Shire to boost drug portfolio
Shire, which is based in Lexington, Massachusetts, but listed in London, gained as much as 26 percent after the announcement.
